Home
Contact
|
Sitemap
|
News
|
For Patients
Q&A about EPITARGET
About epilepsy
Results
EPITARGET CDEs
First Results
Publications
Press Release
The group
The Team
Lund University
Life & Brain
Microvitae
University of Eastern Finland
Istituto di Ricerche Farmacologiche Mario Negri
University of Veterinary Medicine Hannover
University College London
University of Bonn
Nencki
Aix Marseille Université
Imperial College
University of Ferrara
Academisch Medisch Centrum
Ben-Gurion University
GABO:mi
Bioviron
Medizinische Hochschule Hannover
to-BBB technologies
Nanomerics
ARTTIC
Advisory Board
Coordinator
The Project
Objectives
Work Plan
WP1: Identifying novel biomarkers
WP2: Unravelling pathophysiology of epileptogenesis
WP3: Targeting disease-modifying treatments
WP4: Translating knowledge to patient material
WP5: Project Management
WP6: Dissemination
Expected Impact
Meetings
Links
search
Newsletter
Do you wish to update or terminate your subscription?
Enter the email address by which you originally subscribed and we will send to your mailbox links to the update and termination pages of your subscription
News Section
19/06/2019
epiXchange publication in Epilepsia
Recommendations on future epilepsy research published by the epiXchange cluster
Read more
Social Media
